Medical Technology

@xconomy.com 3 years ago

Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D

@xconomy.com 3 years ago

Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue

@xconomy.com 3 years ago

Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later

@xconomy.com 4 years ago

Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses

@xconomy.com 4 years ago

Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA

@xconomy.com 4 years ago

Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal

@xconomy.com 4 years ago

Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B

@xconomy.com 4 years ago

Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow

@xconomy.com 4 years ago

Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More

@xconomy.com 4 years ago

Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company

@xconomy.com 4 years ago

Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D

@xconomy.com 4 years ago

San Diego Life Sciences Roundup: MedCrypt, LunaDNA, Dynacure & More

@xconomy.com 5 years ago

Corza Health Emerges Led by Former NuVasive, GreatCall Executives

@xconomy.com 5 years ago

Connect Honors 7 New Products as ‘Most Innovative’ at Annual Awards

@xconomy.com 5 years ago

Synthorx Files for IPO to Advance Enhanced Cytokine Drugs

@xconomy.com 5 years ago

Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections

@xconomy.com 5 years ago

Six Life Science Firms Close Q3 with an IPO, More Are on the Way

@xconomy.com 5 years ago

Renovia Raises $42M to Back Digital Treatment for Incontinence

@xconomy.com 5 years ago

Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO

@xconomy.com 6 years ago

Histogen Treatment for Female Hair Loss Cleared for Clinical Testing